Pressure Monitoring Market by Product (Oximeters, BP Cuffs, BP Monitors (Digital, Aneroid, Cuffless)), Procedure (Invasive & Non-invasive), Therapeutic Application (Respiratory and Cardiac Disorders, Glaucoma), End User - Global Forecast to 2032
압력 모니터링 시장 규모는 2025년 145억 6,000만 달러에서 2032년에는 254억 8,000만 달러에 달할 것으로 예측되며, 2025년부터 2032년까지 8.3%의 CAGR을 기록할 것으로 예상됩니다.
| 조사 범위 |
| 조사 대상 연도 |
2024-2032년 |
| 기준 연도 |
2024년 |
| 예측 기간 |
2024-2032년 |
| 검토 단위 |
금액(10억 달러) |
| 부문 |
제품별, 시술별, 치료 용도별, 최종사용자별, 지역별 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카 |
비침습적, 휴대형, 커넥티드 모니터링 기기의 개발과 같은 기술 혁신으로 인해 임상 및 가정 환경 모두에서 압력 모니터링의 접근성과 편의성이 향상되고 있습니다. 또한, 원격의료 서비스의 성장, 의료비 지출의 증가, 예방 의료에 대한 대중의 인식이 높아짐에 따라 조기 진단과 정기적인 건강 모니터링에 기여하고 있습니다. 이러한 요인들은 다양한 의료 환경에서 압력 모니터링 시스템의 채택을 촉진하고 압력 모니터링 시장의 성장을 가속화하고 있습니다.
압력 모니터링 시장은 몇 가지 중요한 요인에 의해 크게 성장하고 있습니다. 이러한 추세의 주요 요인은 고혈압, 심혈관질환, 호흡기질환과 같은 만성질환의 전 세계 유병률의 증가이며, 이러한 질환은 효과적인 관리를 위해 지속적이고 정확한 압력 모니터링이 필요합니다. 노인은 이러한 건강 문제에 더 취약하기 때문에 고령화도 이러한 수요에 큰 역할을 하고 있습니다.
또한, 기술의 발전으로 환자의 편안함을 높이고 원격 모니터링을 용이하게 하는 비침습적이고 휴대 가능한 스마트 기기가 개발되고 있습니다. 이는 원격의료 및 재택의료의 증가 추세와 일치합니다. 또한, 의료비 지출 증가, 의료 인프라 확대, 조기 진단 및 예방 의료에 대한 인식 증가도 세계 시장 성장의 원동력이 되고 있습니다.
이러한 요인들은 지속적인 건강 관리가 필요한 노인 인구와 결합하여 다양한 의료 환경에서 기압 모니터링 시스템의 채택을 가속화하고 있습니다.
광범위한 압력 모니터링 시장에서 폐압 모니터링의 성장은 특히 고령 인구와 만성폐쇄성폐질환(COPD) 또는 심부전 환자에서 폐고혈압 및 기타 호흡기 관련 합병증 발생률의 증가에 의해 주도되고 있습니다. 심각한 결과를 예방하기 위해 폐혈관 이상을 조기에 발견하는 것이 중요해지고 있으며, 이에 따라 의료 시스템은 보다 정확하고 실시간 폐압 평가 도구를 채택하고 있습니다. 특히 중환자실 및 심폐 환경에서의 최소침습적 이식형 모니터링 기술로의 전환은 이러한 채택을 더욱 가속화하고 있습니다. 또한, 치료 계획을 최적화하는 데 있어 폐압 모니터링의 중요성을 뒷받침하는 임상 가이드라인과 연구가 증가하면서 이 틈새시장이지만 중요한 시장 분야에 대한 투자와 기술 혁신을 촉진하고 있습니다.
중환자실 및 수술 환경에서 실시간 정밀 모니터링에 대한 수요가 증가함에 따라 침습적 압력 모니터링 시장의 성장을 촉진하고 있습니다. 동맥압 및 두개내압 측정과 같은 기술은 심각한 심혈관질환, 신경 질환, 외상성 질환을 앓고 있는 환자를 관리하는 데 필수적입니다.
특히 고령화 인구와 여러 합병증을 가진 환자들 사이에서 복잡한 수술이 증가함에 따라 수술 중 및 중환자실에서의 지속적인 모니터링의 필요성이 증가하고 있습니다. 또한, 선진국의 의료 시스템에서는 중환자실의 고도화와 전문 의료 인력의 충원이 침습적 모니터링 방법의 광범위한 채택을 촉진하고 있습니다.
병원과 수술 센터가 환자의 안전과 진단 및 치료의 정확성을 우선시하는 가운데, 침습적 압력 모니터링은 여전히 급성기 임상 환경에서 필수적인 요소로 자리 잡고 있습니다.
치료 용도별로는 호흡기질환이 압력 모니터링 시장에서 가장 큰 점유율을 차지하고 있습니다.
호흡기질환의 증가는 압력 모니터링 시스템에 대한 수요를 크게 촉진하고 있으며, 이는 환경 및 생활습관 관련 건강 문제의 증가와 밀접한 관련이 있습니다. 대기 오염 증가, 유해 입자에 대한 직업적 노출, 흡연, 호흡기 감염의 장기적인 영향 등의 요인이 COPD, 천식, 수면무호흡증과 같은 만성 호흡기질환의 급증에 기여하고 있습니다.
이러한 질환에서는 환기 및 산소 요법을 효과적으로 관리하기 위해 흉강 내 압력과 기도 압력을 정확하고 지속적으로 모니터링해야 합니다. 또한 병원과 가정 간호 모두에서 기계적 환기 및 비침습적 호흡 지원의 사용이 증가함에 따라 압력 모니터링 시스템의 필요성이 크게 증가하고 있습니다.
의료 서비스 제공자가 조기 개입과 적극적인 질병 관리에 중점을 두고 있는 가운데, 정확한 압력 측정 도구는 임상 결과를 개선하고 호흡기질환 환자의 재입원을 줄이기 위해 필수적입니다.
홈케어 환경에서 압력 모니터링의 성장은 몇 가지 중요한 요인에 의해 이루어지고 있습니다. 첫째, 고혈압 및 심혈관질환과 같은 만성질환의 유병률이 증가함에 따라 지속적인 모니터링이 필요하며, 재택 기반 솔루션이 더욱 매력적으로 다가오고 있습니다. 또한, 기술의 발전으로 자가 관리를 용이하게 하고, 잦은 병원 방문의 필요성을 줄여주며, 사용하기 쉽고, 휴대 가능하며, 정확한 모니터링 기기의 개발이 진행되고 있습니다.
또한, 고령화 사회는 집에서 편안하게 치료를 받는 것을 선호하기 때문에 재택의료 모니터링 솔루션에 대한 수요가 더욱 증가하고 있습니다. 의료 정책 및 상환 구조의 변화도 재택 치료를 지원하도록 진화하고 있으며, 이는 환자와 의료 제공자 모두에게 보다 현실적인 선택이 되고 있습니다. 이러한 요인들이 복합적으로 작용하여 재택의료에서 체압 모니터링의 역할이 커지고 있습니다.
지역별로는 북미가 2024년 압력 모니터링 시장에서 가장 큰 점유율을 차지하고 있습니다.
북미 체압 모니터링 시장의 성장은 첨단 헬스케어 기술과 환자 중심의 케어 모델에 대한 관심이 높아지면서 성장세를 보이고 있습니다. 헬스케어 IT 인프라에 대한 투자가 증가함에 따라 압력 모니터링 기기와 전자 의료 기록 및 원격의료 플랫폼과의 통합이 가능해져 보다 효율적이고 협력적인 환자 관리가 가능해졌습니다. 또한, 북미의 엄격한 규제 프레임워크와 품질 기준은 신뢰할 수 있는 혁신적인 모니터링 솔루션의 채택을 촉진하고 있습니다.
가치 기반 의료로의 전환은 의료 서비스 제공자가 임상 결과를 개선하고 병원 재입원을 줄이기 위해 지속적 압력 모니터링을 사용하도록 유도하고 있습니다. 또한, 심혈관 건강에 초점을 맞춘 인식 개선 캠페인과 질병을 조기에 발견하기 위한 정부 프로그램으로 인해 임상 및 재택 치료 환경 모두에서 압력 모니터링 기기에 대한 수요가 증가하고 있습니다.
세계의 압력 모니터링 시장에 대해 조사했으며, 제품별, 시술별, 치료 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 정리하여 전해드립니다.
목차
제1장 소개
제2장 조사 방법
제3장 주요 요약
제4장 주요 인사이트
제5장 시장 개요
- 소개
- 시장 역학
- 업계 동향
- 기술 분석
- Porter's Five Forces 분석
- 규제 상황
- 특허 분석
- 무역 분석
- 가격 분석
- 2025-2026년의 주요 회의와 이벤트
- 주요 이해관계자와 구입 기준
- 압력 모니터링 시장의 미충족 수요/최종사용자 기대
- AI/생성형 AI가 압력 모니터링 시장에 미치는 영향
- 밸류체인 분석
- 공급망 분석
- 생태계 분석
- 사례 연구 분석
- 압력 모니터링 시장 인접 시장
- 고객의 비즈니스에 영향을 미치는 동향/혼란
- 투자와 자금 조달 시나리오
- 2025년 미국 관세가 압력 모니터링 시장에 미치는 영향
제6장 압력 모니터링 시장(제품별)
제7장 압력 모니터링 시장(시술별)
제8장 압력 모니터링 시장(치료 용도별)
- 소개
- 호흡기질환
- 녹내장
- 심장질환
- 신경질환
- 투석
- 기타
제9장 압력 모니터링 시장(최종사용자별)
- 소개
- 병원과 클리닉
- 외래 진료 센터
- 재택 케어
- 긴급 치료실
- 프라이머리 센터
- 기타
제10장 압력 모니터링 시장(지역별)
- 소개
- 북미
- 유럽
- 유럽의 거시경제 전망
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타
- 아시아태평양
- 아시아태평양의 거시경제 전망
- 중국
- 일본
- 인도
- 한국
- 호주
- 기타
- 라틴아메리카
- 라틴아메리카의 거시경제 전망
- 브라질
- 멕시코
- 기타
- 중동 및 아프리카
- 중동 및 아프리카의 거시경제 전망
- GCC 국가
- 기타
제11장 경쟁 구도
- 개요
- 주요 진출 기업의 전략/강점
- 매출 분석
- 시장 점유율 분석
- 기업 평가 매트릭스 : 주요 진출 기업, 2024년
- 기업 평가 매트릭스 : 스타트업/중소기업, 2024년
- 기업 평가와 재무 지표
- 브랜드/제품 비교 분석
- 주요 기업의 R&D 평가
- 경쟁 시나리오
제12장 기업 개요
- 주요 진출 기업
- MEDTRONIC
- KONINKLIJKE PHILIPS N.V.
- GE HEALTHCARE
- OMRON CORPORATION.
- DRAGERWERK AG & CO. KGAA
- ABBOTT
- BAXTER INTERNATIONAL, INC.
- TERUMO CORPORATION
- BECTON, DICKINSON AND COMPANY(BD)
- NIHON KOHDEN CORPORATION
- INTEGRA LIFESCIENCES CORPORATION
- ZEISS GROUP
- BOSTON SCIENTIFIC CORPORATION
- ICU MEDICAL, INC.
- MASIMO CORPORATION
- 기타 기업
- REICHERT, INC.
- NONIN
- NATUS
- HONSUN
- ROSSMAX INTERNATIONAL LTD.
- MICROLIFE CORPORATION
- A&D COMPANY
- PAUL HARTMANN ASIA-PACIFIC LTD.
- ICARE FINLAND OY.
- IHEALTH LABS INC.
제13장 부록
ksm
The pressure monitoring market is projected to reach USD 25.48 billion by 2032 from USD 14.56 billion in 2025, at a CAGR of 8.3% from 2025 to 2032.
| Scope of the Report |
|---|
| Years Considered for the Study | 2024-2032 |
| Base Year | 2024 |
| Forecast Period | 2024-2032 |
| Units Considered | Value (USD billion) |
| Segments | Product, Procedure, Therapeutic Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Technological innovations, such as the development of non-invasive, portable, and connected monitoring devices, have improved the accessibility and convenience of pressure monitoring in both clinical and home settings. Furthermore, the growth of telehealth services, increasing healthcare expenditures, and a heightened public awareness of preventive care are all contributing to early diagnosis and regular health monitoring. These factors are driving the adoption of pressure monitoring systems across various healthcare environments, thereby accelerating the growth of the pressure monitoring market.
The pressure monitoring market is experiencing substantial growth, driven by several key factors. A major contributor to this trend is the increasing global prevalence of chronic diseases such as hypertension, cardiovascular disorders, and respiratory conditions, which require continuous and accurate pressure monitoring for effective management. The aging population also plays a significant role in this demand, as older adults are more vulnerable to these health issues.
Additionally, advancements in technology have led to the creation of non-invasive, portable, and smart devices that enhance patient comfort and facilitate remote monitoring. This aligns with the rising trend of telehealth and home-based care. Moreover, increasing healthcare expenditures, expanding healthcare infrastructure, and heightened awareness about early diagnosis and preventive care are also fueling market growth worldwide.
Together, these factors, combined with an older population that needs ongoing health management, are accelerating the adoption of pressure monitoring systems across various healthcare settings.
Based on products, pulmonary pressure monitors accounted for the second-largest share in the pressure monitoring market.
The growth of pulmonary pressure monitoring within the broader pressure monitoring market is being driven by the rising incidence of pulmonary hypertension and other respiratory-related complications, especially among aging populations and patients with chronic obstructive pulmonary disease (COPD) or heart failure. There is an increasing emphasis on the early detection of pulmonary vascular abnormalities to prevent severe outcomes, which is prompting healthcare systems to adopt more precise and real-time pulmonary pressure assessment tools. The shift towards minimally invasive and implantable monitoring technologies has further accelerated this adoption, particularly in critical care and cardiopulmonary settings. Additionally, clinical guidelines and research are increasingly supporting the importance of pulmonary pressure monitoring in optimizing treatment plans, thus driving investment and innovation in this niche yet vital segment of the market.
Based on procedures, invasive procedures registered the highest CAGR during the forecast period.
The increasing demand for real-time, high-precision monitoring in critical care and surgical settings is driving the growth of invasive procedures in the pressure monitoring market. Techniques such as arterial and intracranial pressure measurements are essential for managing patients with severe cardiovascular, neurological, or traumatic conditions, as immediate and accurate readings can significantly impact their outcomes.
The rise in complex surgeries, particularly among aging populations and patients with multiple comorbidities, has heightened the need for continuous intraoperative and ICU monitoring. Additionally, the growing sophistication of critical care units and the greater availability of specialized medical personnel in developed healthcare systems are supporting the wider adoption of invasive monitoring methods.
As hospitals and surgical centers prioritize patient safety and precision in diagnosis and treatment, invasive pressure monitoring remains a vital component in high-acuity clinical environments.
Based on therapeutic applications, respiratory disorders hold the largest share of the pressure monitoring market.
The rise in respiratory disorders is significantly driving the demand for pressure monitoring systems, which is closely linked to increasing environmental and lifestyle-related health challenges. Factors such as rising air pollution, occupational exposure to harmful particles, smoking, and the long-term effects of respiratory infections have contributed to a surge in chronic respiratory diseases like COPD, asthma, and sleep apnea.
These conditions often necessitate precise and continuous monitoring of intrathoracic and airway pressures to effectively manage ventilation and oxygen therapy. Additionally, the growing use of mechanical ventilation and non-invasive respiratory support in both hospital and home care settings has led to a substantial increase in the need for pressure monitoring systems.
As healthcare providers focus on early intervention and proactive disease management, accurate pressure measurement tools have become essential for improving clinical outcomes and reducing hospital readmissions for patients with respiratory conditions.
By end user, home care settings dominated the pressure monitoring market in 2024.
The growth of pressure monitoring in home care settings is driven by several key factors. First, there is an increasing prevalence of chronic diseases, such as hypertension and cardiovascular disorders, which require continuous monitoring and make home-based solutions more appealing. Additionally, technological advancements have led to the development of user-friendly, portable, and accurate monitoring devices that facilitate self-management and reduce the need for frequent hospital visits.
Furthermore, the aging population prefers to receive care in the comfort of their own homes, which further boosts the demand for homecare monitoring solutions. Changes in healthcare policies and reimbursement structures are also evolving to support home-based care, making it a more viable option for both patients and providers. Collectively, these factors contribute to the growing role of pressure monitoring in home care settings.
By region, North America accounted for the largest share of the pressure monitoring market in 2024.
The growth of the pressure monitoring market in North America is driven by a strong emphasis on advanced healthcare technologies and patient-centered care models. Increased investments in healthcare IT infrastructure have enabled the integration of pressure monitoring devices with electronic health records and telehealth platforms, resulting in more efficient and coordinated patient management. Moreover, strict regulatory frameworks and quality standards in North America promote the adoption of highly reliable and innovative monitoring solutions.
The shift towards value-based care is encouraging healthcare providers to utilize continuous pressure monitoring to improve clinical outcomes and reduce hospital readmissions. Additionally, awareness campaigns focused on cardiovascular health, as well as government programs aimed at early disease detection, are increasing the demand for pressure monitoring devices in both clinical and home care settings.
A breakdown of the primary participants (supply side) for the pressure monitoring market referred to in this report is provided below:
- By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
- By Designation: C-level Executives (20%), D-level Executives (35%), and Others (45%)
- By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)
The key players in the pressure monitoring market are Medtronic (US), Omron Corporation (Japan), Dragerwerk AG & Co. KGaA (Germany), Abbott (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Baxter (US), Terumo Corporation (Japan), BD (US), Nihon Kohden Corporation (Japan), Integra LifeSciences Corporation (US), Zeiss Group (Germany), Boston Scientific Corporation (US), HONSUN (China), A&D Company (Japan), Reichert, Inc. (US), Nonin. (US), Mehra Eyetech Pvt. Ltd. (India), Rossmax International Ltd. (China), Microlife Corporation. (China), SunTech Medical, Inc. (US), PAUL HARTMANN Asia-Pacific Ltd. (Canada), Icare Finland Oy (Finland), and iHealth Labs Inc. (US).
Research Coverage
The report analyzes the pressure monitoring market and estimates its size and future growth potential based on various segments such as product, procedure, therapeutic area, end user, and region. It also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report is designed to assist both market leaders and new entrants by providing valuable insights into the overall pressure monitoring market, including detailed revenue estimates for its subsegments. It will help stakeholders comprehend the competitive landscape, allowing them to better position their businesses and develop effective go-to-market strategies. Additionally, the report highlights key market drivers, restraints, challenges, and opportunities, enabling stakeholders to understand current market trends and dynamics.
This report provides insights into the following pointers:
- Analysis of key drivers (growing prevalence of chronic diseases, technological advancements and integration with digital health platforms, shift towards home healthcare and remote monitoring, and aging population and increased healthcare expenditure), restraints (regulatory and compliance challenges and data privacy and security concerns), opportunities (development of non-invasive and wearable pressure monitoring devices and growth in emerging markets and telehealth infrastructure), and challenges (limited availability of skilled professionals)
- Market Penetration: It provides detailed information on products available from major players in the global pressure monitoring market. The report covers various segments, including products, procedures, therapeutic areas, end users, and regions
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global pressure monitoring market
- Market Development: Thorough knowledge and analysis of the profitable rising markets by product, procedure, therapeutic application, end user, and region
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global pressure monitoring market
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global pressure monitoring market
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
- 1.5 MARKET LIMITATIONS
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH APPROACH
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Primary sources
- 2.1.2.2 Key data from primary sources
- 2.1.2.3 Breakdown of primaries
- 2.2 MARKET SIZE ESTIMATION
- 2.3 GROWTH FORECAST
- 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
- 2.5 KEY INDUSTRY INSIGHTS
- 2.6 RESEARCH IMITATIONS
- 2.6.1 METHODOLOGY-RELATED LIMITATIONS
- 2.7 RISK ASSESSMENT
- 2.8 STUDY ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 PRESSURE MONITORING MARKET OVERVIEW
- 4.2 NORTH AMERICA: PRESSURE MONITORING MARKET, BY PRODUCT & COUNTRY (2024)
- 4.3 PRESSURE MONITORING MARKET: REGIONAL MIX, 2025 VS. 2032
- 4.4 PRESSURE MONITORING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 4.5 PRESSURE MONITORING MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Growing prevalence of chronic diseases
- 5.2.1.2 Integration with digital health platforms and rising technological advancements
- 5.2.1.3 Gradual shift towards remote monitoring and home healthcare
- 5.2.1.4 Expanding geriatric population and rising healthcare expenditure
- 5.2.2 RESTRAINTS
- 5.2.2.1 Stringent regulatory guidelines for commercialization of medical devices
- 5.2.2.2 Concerns associated with data privacy & security
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Development of non-invasive & wearable pressure monitoring devices
- 5.2.3.2 Expansion of telehealth infrastructure in emerging economies
- 5.2.4 CHALLENGES
- 5.2.4.1 Limited availability of skilled professionals
- 5.3 INDUSTRY TRENDS
- 5.3.1 INTEGRATION OF WIRELESS CONNECTIVITY AND IOT IN PRESSURE MONITORING DEVICES
- 5.4 TECHNOLOGY ANALYSIS
- 5.4.1 KEY TECHNOLOGIES
- 5.4.1.1 MEMS (Micro-Electro-Mechanical Systems) sensors
- 5.4.1.2 Wireless connectivity & cloud integration
- 5.4.2 COMPLEMENTARY TECHNOLOGIES
- 5.4.2.1 AI & predictive analytics
- 5.4.2.2 Wearable electronics & flexible materials
- 5.5 PORTER'S FIVE FORCES ANALYSIS
- 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.5.2 BARGAINING POWER OF BUYERS
- 5.5.3 BARGAINING POWER OF SUPPLIERS
- 5.5.4 THREAT OF SUBSTITUTES
- 5.5.5 THREAT OF NEW ENTRANTS
- 5.6 REGULATORY LANDSCAPE
- 5.6.1 REGULATORY FRAMEWORK
- 5.6.1.1 North America
- 5.6.1.2 Europe
- 5.6.1.3 Asia Pacific
- 5.6.1.3.1 Japan
- 5.6.1.3.2 China
- 5.6.1.3.3 India
- 5.6.1.4 Latin America
- 5.6.1.5 Middle East & Africa
- 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.7 PATENT ANALYSIS
- 5.7.1 PATENT PUBLICATION TRENDS FOR BLOOD PRESSURE MONITORING MARKET
- 5.8 TRADE ANALYSIS
- 5.8.1 IMPORT DATA FOR HS CODE 901890, 2020-2025
- 5.8.2 EXPORT DATA FOR HS CODE 901890, 2020-2025
- 5.9 PRICING ANALYSIS
- 5.9.1 INDICATIVE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022-2024)
- 5.9.2 INDICATIVE SELLING PRICE TREND OF PRESSURE MONITORING PRODUCTS, BY REGION
- 5.10 KEY CONFERENCES & EVENTS, 2025-2026
- 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.11.2 BUYING CRITERIA
- 5.12 UNMET NEEDS/END-USER EXPECTATIONS IN PRESSURE MONITORING MARKET
- 5.13 IMPACT OF AI/GENERATIVE AI ON PRESSURE MONITORING MARKET
- 5.14 VALUE CHAIN ANALYSIS
- 5.15 SUPPLY CHAIN ANALYSIS
- 5.16 ECOSYSTEM ANALYSIS
- 5.17 CASE STUDY ANALYSIS
- 5.17.1 CASE STUDY 1: MEDTRONIC INTEGRATED CRITICAL CARE PLATFORM CAPABILITIES INTO PRESSURE MONITORING DEVICES
- 5.17.2 CASE STUDY 2: IMPLEMENTATION OF ADVANCED INVASIVE PRESSURE MONITORING SOLUTIONS ACROSS CRITICAL CARE SETTINGS BY GE HEALTHCARE
- 5.17.3 CASE STUDY 3: ENHANCED ACCURACY & USABILITY IN HOME MONITORING BY OMRON HEALTHCARE
- 5.18 ADJACENT MARKETS FOR PRESSURE MONITORING MARKET
- 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.20 INVESTMENT & FUNDING SCENARIO
- 5.21 IMPACT OF 2025 US TARIFF ON PRESSURE MONITORING MARKET
- 5.21.1 KEY TARIFF RATES
- 5.21.2 PRICE IMPACT ANALYSIS
- 5.21.3 IMPACT ON COUNTRY/REGION
- 5.21.3.1 North America
- 5.21.3.2 Europe
- 5.21.3.3 Asia Pacific
- 5.21.4 IMPACT ON END-USER INDUSTRIES
- 5.21.4.1 Hospitals
- 5.21.4.2 Home care settings
- 5.21.4.3 Ambulatory care centers
6 PRESSURE MONITORING MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 DEVICES
- 6.2.1 BLOOD PRESSURE MONITORS, BY TYPE
- 6.2.1.1 Sphygmomanometers
- 6.2.1.1.1 Rising rates of hypertension to boost demand
- 6.2.1.2 Blood pressure transducers
- 6.2.1.2.1 Conversion of physiological blood pressure signals into electronic outputs to fuel market
- 6.2.1.3 Ambulatory blood pressure monitors
- 6.2.1.3.1 Growing focus on RPM services to drive market
- 6.2.1.4 Automated blood pressure monitors
- 6.2.1.4.1 Increasing preference for personalized health management to propel market
- 6.2.1.5 Cuffless blood pressure monitors
- 6.2.1.5.1 Integration of technological advancements into wearable devices to fuel market
- 6.2.2 BLOOD PRESSURE MONITORS, BY TECHNOLOGY
- 6.2.2.1 Digital blood pressure monitors
- 6.2.2.1.1 Improved accuracy & precision to support market growth
- 6.2.2.2 Aneroid blood pressure monitors
- 6.2.2.2.1 Proven efficacy across clinical settings to boost demand
- 6.2.2.3 Wearable blood pressure monitors
- 6.2.2.3.1 Cuff-based blood pressure monitors
- 6.2.2.3.2 Cuffless blood pressure monitors
- 6.2.2.3.2.1 Wrist-based monitors
- 6.2.2.3.2.1.1 Advancements in sensor technology and miniaturization to fuel uptake
- 6.2.2.3.2.2 Finger-based Monitors
- 6.2.2.3.2.2.1 Digital integration to accelerate demand
- 6.2.2.3.2.3 Arm band-based monitors
- 6.2.2.3.2.3.1 Continuous monitoring and fitness health tracking insights to boost demand
- 6.2.3 INTRAOCULAR PRESSURE MONITORS
- 6.2.3.1 Increasing prevalence of glaucoma to boost demand
- 6.2.4 PULMONARY PRESSURE MONITORS
- 6.2.4.1 Oximeters
- 6.2.4.1.1 Rising incidence of respiratory & infectious diseases to propel market
- 6.2.4.2 Capnography
- 6.2.4.2.1 Increasing prevalence of COPD and ARDS to support market uptake
- 6.2.4.3 Spirometers
- 6.2.4.3.1 Introduction of portable and digital spirometers to aid market growth
- 6.2.5 INTRACRANIAL PRESSURE MONITORS
- 6.2.5.1 Surge in neurological disorders to boost demand
- 6.2.6 OTHER MONITORING DEVICES
- 6.3 ACCESSORIES
- 6.3.1 BLOOD PRESSURE ACCESSORIES, BY TYPE
- 6.3.1.1 Blood pressure/cardiac monitoring accessories
- 6.3.1.1.1 Blood pressure cuffs
- 6.3.1.1.1.1 Availability of manual & automatic models to aid market
- 6.3.1.1.2 Bulbs
- 6.3.1.1.2.1 Utilized in conjunction with sphygmomanometers for accurate measurement to drive market
- 6.3.1.1.3 Manometers
- 6.3.1.1.3.1 Rising demand due to hypertension to support market growth
- 6.3.1.1.4 Tubes & valves
- 6.3.1.1.4.1 Focus on accurate measurement in clinical settings to fuel uptake
- 6.3.1.2 Intraocular pressure monitoring accessories
- 6.3.1.2.1 Tip covers/Tonocovers
- 6.3.1.2.1.1 Advancements in ocular surgery to drive market
- 6.3.1.2.2 Prisms
- 6.3.1.2.2.1 Increasing incidence of cataracts to fuel uptake
- 6.3.1.2.3 Sensors
- 6.3.1.2.3.1 Integration of IOP sensors into clinical practice to support market uptake
- 6.3.1.3 Pulmonary pressure monitoring accessories
- 6.3.1.3.1 Mouthpieces
- 6.3.1.3.1.1 Growing effectiveness in non-invasive ventilation to boost demand
- 6.3.1.3.2 Filters
- 6.3.1.3.2.1 Growing emphasis on infection control practices to aid market
- 6.3.1.3.3 Nasal probes & plugs
- 6.3.1.3.3.1 Focus on enhanced respiratory airflow and monitoring to fuel market
- 6.3.1.4 Other pressure monitoring accessories
- 6.3.2 ACCESSORIES, BY USABILITY
- 6.3.2.1 Disposable accessories
- 6.3.2.1.1 Increasing adoption of single-use accessories for patient safety to boost demand
- 6.3.2.2 Reusable accessories
- 6.3.2.2.1 Emphasis on sustainable healthcare practices to support market growth
7 PRESSURE MONITORING MARKET, BY PROCEDURE
- 7.1 INTRODUCTION
- 7.2 INVASIVE PROCEDURES
- 7.2.1 ABILITY TO BALANCE CLINICAL ACCURACY & PATIENT SAFETY IN HIGH-ACUITY PRESSURE MONITORING SYSTEMS TO DRIVE MARKET
- 7.3 NON-INVASIVE PROCEDURES
- 7.3.1 AI & ML INTEGRATION WITH REAL-MONITORING INSIGHTS TO BOOST DEMAND
8 PRESSURE MONITORING MARKET, BY THERAPEUTIC APPLICATION
- 8.1 INTRODUCTION
- 8.2 RESPIRATORY DISORDERS
- 8.2.1 INCREASING INCIDENCE OF COPD AND ASTHMA TO DRIVE MARKET
- 8.3 GLAUCOMA
- 8.3.1 DEVELOPMENT OF MINIMALLY INVASIVE SENSOR-BASED DEVICES TO FUEL UPTAKE
- 8.4 CARDIAC DISORDERS
- 8.4.1 HIGH PREVALENCE OF MYOCARDIAL INFARCTION AND HYPERTENSION TO PROPEL MARKET
- 8.5 NEUROLOGICAL DISORDERS
- 8.5.1 CASES OF TBHI AND HEMORRHAGE TO FUEL ADOPTION
- 8.6 DIALYSIS
- 8.6.1 INCREASING PREVALENCE OF CKD TO SUPPORT MARKET GROWTH
- 8.7 OTHER THERAPEUTIC APPLICATIONS
9 PRESSURE MONITORING MARKET, BY END USER
- 9.1 INTRODUCTION
- 9.2 HOSPITALS & CLINICS
- 9.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO DRIVE MARKET
- 9.3 AMBULATORY CARE CENTERS
- 9.3.1 GROWING DEMAND FOR REAL-TIME PATIENT MONITORING ACROSS CRITICAL CARE TO FUEL MARKET
- 9.4 HOME CARE SETTINGS
- 9.4.1 ENHANCED PATIENT CONVENIENCE & SAFETY TO PROPEL MARKET
- 9.5 URGENT CARE SETTINGS
- 9.5.1 RISING NEED FOR TIMELY DECISION-MAKING FOR TRAUMA CASES TO BOOST DEMAND
- 9.6 PRIMARY CENTERS
- 9.6.1 GROWING FOCUS ON ENHANCED PATIENT OUTCOMES TO SUPPORT MARKET UPTAKE
- 9.7 OTHER END USERS
10 PRESSURE MONITORING MARKET, BY REGION
- 10.1 INTRODUCTION
- 10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
- 10.2.2.1 Established healthcare infrastructure and high volume of chronic diseases to drive market
- 10.2.3 CANADA
- 10.2.3.1 Favorable government initiatives for digital health integration to boost demand
- 10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
- 10.3.2.1 Increasing cases of hypertension to fuel market
- 10.3.3 UK
- 10.3.3.1 High burden of contagious diseases to boost demand
- 10.3.4 FRANCE
- 10.3.4.1 Expansive growth in medical devices industry to aid market
- 10.3.5 ITALY
- 10.3.5.1 Adoption of cuffless blood pressure monitoring devices to drive market
- 10.3.6 SPAIN
- 10.3.6.1 Government initiatives on advanced medical equipment to fuel uptake
- 10.3.7 REST OF EUROPE
- 10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
- 10.4.2.1 Favorable policies for healthcare modernization to support market growth
- 10.4.3 JAPAN
- 10.4.3.1 Increasing geriatric population and rise in age-associated target conditions to boost demand
- 10.4.4 INDIA
- 10.4.4.1 Improvements in healthcare infrastructure to fuel market
- 10.4.5 SOUTH KOREA
- 10.4.5.1 Growing focus on national health programs and public health initiatives to drive market
- 10.4.6 AUSTRALIA
- 10.4.6.1 Increasing funding investments for non-invasive monitoring technologies to boost demand
- 10.4.7 REST OF ASIA PACIFIC
- 10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
- 10.5.2.1 Growing focus on home healthcare to support market
- 10.5.3 MEXICO
- 10.5.3.1 Increasing focus on telehealth integration to drive market
- 10.5.4 REST OF LATIN AMERICA
- 10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 10.6.2 GCC COUNTRIES
- 10.6.2.1 Kingdom of Saudi Arabia (KSA)
- 10.6.2.1.1 Increasing cases of infectious diseases to boost demand
- 10.6.2.2 United Arab Emirates (UAE)
- 10.6.2.2.1 Increasing prevalence of CVD to drive market
- 10.6.2.3 Other GCC Countries
- 10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
- 11.1 OVERVIEW
- 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.3 REVENUE ANALYSIS
- 11.4 MARKET SHARE ANALYSIS
- 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 11.5.5.1 Company footprint
- 11.5.5.2 Region footprint
- 11.5.5.3 Product footprint
- 11.5.5.4 Procedure type footprint
- 11.5.5.5 Therapeutic application footprint
- 11.5.5.6 End-user footprint
- 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 DYNAMIC COMPANIES
- 11.6.3 STARTING BLOCKS
- 11.6.4 RESPONSIVE COMPANIES
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 11.6.5.1 Detailed list of key startups/SME players
- 11.6.5.2 Competitive benchmarking of startups/SMEs
- 11.7 COMPANY VALUATION & FINANCIAL METRICS
- 11.7.1 FINANCIAL METRICS
- 11.7.2 COMPANY VALUATION
- 11.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
- 11.9 R&D ASSESSMENT OF KEY PLAYERS
- 11.10 COMPETITIVE SCENARIO
- 11.10.1 PRODUCT LAUNCHES & APPROVALS
- 11.10.2 DEALS
- 11.10.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- 12.1.1 MEDTRONIC
- 12.1.1.1 Business overview
- 12.1.1.2 Products offered
- 12.1.1.3 Recent developments
- 12.1.1.3.1 Product approvals
- 12.1.1.3.2 Deals
- 12.1.1.4 MnM view
- 12.1.1.4.1 Key strengths
- 12.1.1.4.2 Strategic choices
- 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 KONINKLIJKE PHILIPS N.V.
- 12.1.2.1 Business overview
- 12.1.2.2 Products offered
- 12.1.2.3 Recent developments
- 12.1.2.3.1 Deals
- 12.1.2.3.2 Expansions
- 12.1.2.4 MnM view
- 12.1.2.4.1 Key strengths
- 12.1.2.4.2 Strategic choices
- 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 GE HEALTHCARE
- 12.1.3.1 Business overview
- 12.1.3.2 Products offered
- 12.1.3.3 Recent developments
- 12.1.3.3.1 Product approvals
- 12.1.3.3.2 Deals
- 12.1.3.4 MnM view
- 12.1.3.4.1 Key strengths
- 12.1.3.4.2 Strategic choices
- 12.1.3.4.3 Weaknesses & competitive threats
- 12.1.4 OMRON CORPORATION.
- 12.1.4.1 Business overview
- 12.1.4.2 Products offered
- 12.1.4.3 Recent developments
- 12.1.4.4 MnM view
- 12.1.4.4.1 Key strengths
- 12.1.4.4.2 Strategic choices
- 12.1.4.4.3 Weaknesses & competitive threats
- 12.1.5 DRAGERWERK AG & CO. KGAA
- 12.1.5.1 Business overview
- 12.1.5.2 Products offered
- 12.1.5.3 MnM view
- 12.1.5.3.1 Key strengths
- 12.1.5.3.2 Strategic choices
- 12.1.5.3.3 Weaknesses & competitive threats
- 12.1.6 ABBOTT
- 12.1.6.1 Business overview
- 12.1.6.2 Products offered
- 12.1.6.3 Recent developments
- 12.1.6.3.1 Product approvals
- 12.1.6.3.2 Deals
- 12.1.7 BAXTER INTERNATIONAL, INC.
- 12.1.7.1 Business overview
- 12.1.7.2 Products offered
- 12.1.7.3 Recent developments
- 12.1.8 TERUMO CORPORATION
- 12.1.8.1 Business overview
- 12.1.8.2 Products offered
- 12.1.8.3 Recent developments
- 12.1.9 BECTON, DICKINSON AND COMPANY (BD)
- 12.1.9.1 Business overview
- 12.1.9.2 Products offered
- 12.1.9.3 Recent developments
- 12.1.10 NIHON KOHDEN CORPORATION
- 12.1.10.1 Business overview
- 12.1.10.2 Products offered
- 12.1.11 INTEGRA LIFESCIENCES CORPORATION
- 12.1.11.1 Business overview
- 12.1.11.2 Products offered
- 12.1.12 ZEISS GROUP
- 12.1.12.1 Business overview
- 12.1.12.2 Products offered
- 12.1.13 BOSTON SCIENTIFIC CORPORATION
- 12.1.13.1 Business overview
- 12.1.13.2 Products offered
- 12.1.14 ICU MEDICAL, INC.
- 12.1.14.1 Business overview
- 12.1.14.2 Products offered
- 12.1.14.3 Recent development
- 12.1.15 MASIMO CORPORATION
- 12.1.15.1 Business overview
- 12.1.15.2 Products offered
- 12.2 OTHER PLAYERS
- 12.2.1 REICHERT, INC.
- 12.2.2 NONIN
- 12.2.3 NATUS
- 12.2.4 HONSUN
- 12.2.5 ROSSMAX INTERNATIONAL LTD.
- 12.2.6 MICROLIFE CORPORATION
- 12.2.7 A&D COMPANY
- 12.2.8 PAUL HARTMANN ASIA-PACIFIC LTD.
- 12.2.9 ICARE FINLAND OY.
- 12.2.10 IHEALTH LABS INC.
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS
